Identification of the Cell Cycle Regulator VCP (p97/CDC48) as a Substrate of the Band 4.1-related Protein-tyrosine Phosphatase PTPH1*

  1. Shao-Hui Zhang,
  2. Jianping Liu,
  3. Ryuji Kobayashi and
  4. Nicholas K. Tonks§
  1. From the Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724

    Abstract

    The human band 4.1-related protein-tyrosine phosphatase PTPH1 was introduced into NIH3T3 cells under the control of a tetracycline-repressible promoter. Ectopic expression of wild type PTPH1 dramatically inhibited cell growth, whereas a catalytically impaired mutant showed no effect. To identify the direct target of PTPH1 in the cell, we generated a substrate-trapping mutant, in which an invariant aspartate residue was changed to alanine (D811A in PTPH1). The PTPH1-D811A mutant trapped primarily a 97-kDa tyrosine-phosphorylated protein, which was determined to be VCP (also named p97 or yeast CDC48), from various cell lysates in vitro. However, when expressed in mammalian cells, the D811A mutant was observed to contain high levels of phosphotyrosine and did not trap substrates. Mutation of tyrosine 676 to phenylalanine (Y676F) in the PTPH1-D811A mutant led to a marked reduction in phosphotyrosine content. Furthermore, this double mutant specifically trapped VCPin vivo and recognized the C-terminal tyrosines of VCP, whose phosphorylation is important for cell cycle progression in yeast. Like wild type PTPH1, this double mutant also inhibited cell proliferation. Moreover, induction of wild type PTPH1 resulted in specific dephosphorylation of VCP without changing the overall phosphotyrosine profile of the cells. VCP has been implicated in control of a variety of membrane functions, including membrane fusions, and is a regulator of the cell cycle. Our results suggest that PTPH1 may exert its effects on cell growth through dephosphorylation of VCP, thus implicating tyrosine phosphorylation as an important regulator of VCP function.

    Footnotes

    • * This work was supported in part by National Institutes of Health Grant CA53840 and the Mellam Family Foundation.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

    • Recipient of a Glaxo-Wellcome Postdoctoral Fellowship. Current address: Tanabe Research Laboratories, 4540 Towne Centre Court, San Diego, CA 92121.

    • § To whom correspondence should be addressed: Cold Spring Harbor Laboratory, 1 Bungtown Rd., Cold Spring Harbor, NY 11724. Tel.: 516-367-8846; Fax: 516-367-6812; E-mail: tonks{at}cshl.org.

    • 2 S.-H. Zhang and N. K. Tonks, unpublished observations.

    • 3 S.-H. Zhang, and N. K. Tonks, unpublished data.

    • Abbreviations:
      PTP

      protein-tyrosine phosphatase

      GST

      glutathioneS-transferase

      VCP

      valosin containing protein

      PAGE

      polyacrylamide gel electrophoresis

      • Received February 4, 1999.
      • Revision received April 7, 1999.
    « Previous | Next Article »Table of Contents
    • Advertisement
    • Advertisement
    Advertisement